A labelled vial mass is not, by itself, a working concentration. To calculate research peptide concentration with confidence, the recorded peptide mass, final solvent volume, unit conversion and supporting analytical documentation must agree. A small transcription error – particularly between micrograms, milligrams, microlitres and millilitres – can compromise comparability across an entire experimental series.
For controlled laboratory work, concentration should be treated as a documented preparation parameter, not an estimate. Record the vial identifier, supplied mass, certificate of analysis details where applicable, solvent, final volume, date, storage conditions and the calculation used. This creates a traceable record that supports repeatability and review.
All materials discussed here are for laboratory, analytical and experimental research use only. They are not for human or animal consumption.
How to calculate research peptide concentration
The basic mass concentration equation is straightforward:
Concentration = mass ÷ volume
If a vial contains 10 mg of peptide and the final reconstitution volume is 2 mL, the calculation is:
10 mg ÷ 2 mL = 5 mg/mL
The resulting stock concentration is 5 mg/mL. That figure is meaningful only when the volume is the final total volume, rather than an assumed volume of solvent added. For most routine preparations, the difference may be small, but it should not be ignored where a method requires tight control.
Mass concentration is commonly expressed as mg/mL, µg/mL or ng/mL. Molar concentration is typically expressed as mM, µM or nM. The appropriate expression depends on the analytical method, assay design and how results will be compared. Keep units consistent from preparation through to data reporting.
Use the correct mass and volume units
Unit errors are one of the most common preventable sources of inaccurate peptide preparations. These reference conversions should be checked before making any calculation:
- 1 g = 1,000 mg
- 1 mg = 1,000 µg
- 1 µg = 1,000 ng
- 1 L = 1,000 mL
- 1 mL = 1,000 µL
For example, 10 mg dissolved to a final volume of 1 mL gives 10 mg/mL. The same concentration can also be written as 10,000 µg/mL or 10 µg/µL. These are equivalent values, but they are not interchangeable with 10 µg/mL. Writing both the number and unit in laboratory records avoids ambiguity.
If the target is 250 µg/mL and the vial contains 5 mg, first convert the mass: 5 mg equals 5,000 µg. Then divide by the target concentration:
5,000 µg ÷ 250 µg/mL = 20 mL
A final volume of 20 mL is required to produce a 250 µg/mL preparation. Always sanity-check the result. If a small vial appears to require an unexpectedly large or very small volume, revisit the units before proceeding.
Moving from mg/mL to molar concentration
Mass concentration is not always sufficient. When experimental design is based on molecular amount, calculate molar concentration using the peptide’s molecular weight or molecular mass as stated in the product documentation or certificate of analysis.
The equation is:
Molarity (mol/L) = mass concentration (g/L) ÷ molecular weight (g/mol)
Suppose a stock solution is 5 mg/mL and the stated molecular weight is 5,000 g/mol. Convert 5 mg/mL to grams per litre first:
5 mg/mL = 5 g/L
Then calculate:
5 g/L ÷ 5,000 g/mol = 0.001 mol/L
This is 1 mM, because 0.001 mol/L equals 1 millimolar. The same stock may therefore be recorded as 5 mg/mL or 1 mM.
Molecular weight must match the material being used. Peptide salts, modified peptides, conjugates and mixtures can have different reported masses from an unmodified sequence. Do not substitute a figure from a general sequence database when a product-specific value is supplied with the verified material. For research requiring molar precision, the product documentation is the relevant starting point.
Account for purity with care
Independent third-party analytical testing and certificates of analysis support identity and purity verification, but purity handling is method-dependent. A purity percentage may be relevant where an assay or analytical calculation specifically requires an estimate of peptide content. It should not be applied automatically without a defined reason and documented approach.
For example, a vial labelled as 10 mg with an assay purity of 98% contains a theoretical 9.8 mg peptide-equivalent for a purity-corrected calculation:
10 mg × 0.98 = 9.8 mg
If that material is brought to a final volume of 2 mL, the purity-corrected estimate is 4.9 mg/mL. However, whether this is the right reporting convention depends on the method. Some workflows use nominal supplied mass for consistency with validated procedures; others require correction based on assay data. Establish the convention before beginning a series and apply it consistently.
Purity is also not the same as identity, water content, counterion content or quantitative assay value. Review the full certificate of analysis rather than relying on a single headline percentage. Where method development demands tighter certainty, consult the relevant laboratory quality procedure and confirm that the available documentation supports the intended calculation.
Calculate dilutions from a prepared stock
Once a stock concentration is known, dilution calculations are most reliably managed using:
C1V1 = C2V2
Here, C1 is the starting concentration, V1 is the volume of stock required, C2 is the desired concentration and V2 is the final volume.
Assume a stock is 5 mg/mL and the method requires 1 mL of a 0.5 mg/mL working solution. Rearranging the equation gives:
V1 = (C2 × V2) ÷ C1
V1 = (0.5 mg/mL × 1 mL) ÷ 5 mg/mL = 0.1 mL
Use 0.1 mL, or 100 µL, of the stock solution and add compatible solvent to reach a final volume of 1 mL. The remaining 900 µL is solvent. State the final volume, rather than simply saying that solvent was added, because the calculation depends on it.
For serial dilutions, record each step separately. Although serial dilution can reduce pipetting demands for very low working concentrations, it introduces cumulative error. A direct dilution may be preferable when volumes remain within the validated operating range of available equipment. The right choice depends on the target concentration, required accuracy and the performance of the pipettes or dispensers in use.
Factors that can affect concentration accuracy
A mathematically correct answer can still be operationally weak if the preparation process is poorly controlled. Hygroscopic material, incomplete dissolution, unsuitable solvent selection, adsorption to surfaces, evaporation and inaccurate dispensing can all affect the concentration available to the experimental system.
Use a solvent compatible with the material and the intended analytical workflow. Follow product-specific storage and handling information where provided. Avoid assuming that every peptide behaves identically after reconstitution; solubility and stability can vary by sequence, modification, formulation and solvent system.
Where the procedure permits, allow adequate time for dissolution and inspect the solution for visible undissolved material or unexpected changes. Do not force a concentration claim where solubilisation has not been confirmed. A clear, contemporaneous note is more useful than an unqualified calculation.
Aliquoting may reduce repeated handling of a prepared stock, but it creates more labelled units to manage. Each aliquot should carry the concentration, solvent, preparation date, storage condition and sample identifier. Controlled labelling reduces the risk of confusing a parent stock with a working dilution.
Documentation that supports reproducible work
A calculation should be easy for another qualified researcher to verify. At minimum, a preparation record should identify the material, batch or lot, labelled mass, relevant certificate data, molecular weight used where applicable, solvent, final volume, calculated concentration and preparer’s initials.
Record the equipment used when precision matters. Pipette range, balance resolution and container type can be relevant to an investigation if results later require review. If an expected mass or volume cannot be achieved reliably with available equipment, revise the preparation plan rather than rounding silently.
Suppliers that provide verified purity and identity data alongside certificates of analysis help establish a reliable documentary starting point. That documentation does not replace method validation within the receiving laboratory, but it supports traceability from supplied material to experimental record.
A precise concentration is not merely a figure on a vial label. It is the result of verified material information, sound unit control, suitable handling and a record another researcher can follow without assumptions.